Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Amylyx Pharmaceuticals Inc’s current trading price is -80.25% away from its 52-week high, while its distance from the 52-week low is 150.16%. The stock’s price range during this period has varied between $1.58 and $19.95. The company, active in the Healthcare sector, saw a trading volume of around 1.54 million for the day, considerably higher average daily volume of 1.14 million observed over the last three months.
The market performance of Amylyx Pharmaceuticals Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $19.95 on 02/29/24, with the lowest value for the same timeframe being $1.58, recorded on 06/17/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Amylyx Pharmaceuticals Inc (AMLX) has experienced a quarterly rise of 85.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 268.24M and boasts a workforce of 384 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.24, with a change in price of +2.11. Similarly, Amylyx Pharmaceuticals Inc recorded 1,488,308 in trading volume during the last 100 days, posting a change of +115.30%.
How AMLX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AMLX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
AMLX Stock Stochastic Average
As of today, the raw stochastic average of Amylyx Pharmaceuticals Inc over the past 50 days is 99.54%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 99.11%. Additionally, the Stochastic %K and %D values for the company were 94.79% and 94.34%, respectively, over the past 20 days.
AMLX Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -73.23% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 96.02%. Over the past 30 days, the price of AMLX has fallen by 48.68%. And in the last five days, it has surged by 20.86%.
